Low-dose aspirin lowers colon cancer risk: study

	Tweet

Low doses of aspirin taken to reduce the risk of heart attacks and strokes can also lower the risk of colon cancer, British researchers reported on Thursday.

They found that aspirin reduced the number of cases of colorectal cancer by a quarter and cut colon cancer deaths by a third.

They said their findings may tip the balance in favor of using aspirin to prevent colon cancer, which is the second most common form of cancer in developed countries after lung cancer.

But their findings, published in the Lancet medical journal, are unlikely to settle a matter that doctors consider controversial.

Many studies have shown that people who take high doses of aspirin are less likely to develop colon cancer and the little growths called polyps that can develop into cancer.

But aspirin itself can be dangerous to many people, causing sometimes deadly bleeding in the stomach and intestines.

Other studies have found that a related painkiller, ibuprofen, can also reduce colon cancer rates among people who take it regularly over the long term.

Peter Rothwell of John Radcliffe Hospital in Oxford and colleagues looked at four big studies of 14,000 people, half of them taking low-dose aspirin for heart disease. These lower doses of aspirin are considered much safer.

Over about 18 years, they reported, 2.8 percent of the volunteers developed colon cancer. Aspirin reduced the 20-year risk of colon cancer by 24 percent and lowered the risk that a patient would die from colon cancer by 35 percent, they said.

“This interesting study would incite clinicians to turn to primary prevention of colorectal cancer by aspirin at least in high risk-populations. Specific guidelines for aspirin chemoprevention would be the next logical step,” Dr. Robert Benamouzig and Dr. Bernard Uzzan of Avicenne Hospital in Bobigny, France, wrote in a commentary.

In many developed countries like the United States and Britain, doctors recommend getting regular cancer checks using instruments that can examine the colon from the inside.

Britain’s National Health Service often opts for a procedure called a sigmoidoscopy, while U.S. experts call for a more comprehensive screening called a colonoscopy.

Both procedures can detect the pre-cancerous growths called polyps so doctors can remove them before they form a tumor, but patients are reluctant to get these uncomfortable and embarrassing tests. Some experts are hoping using cheap drugs like aspirin may be a way to prevent colon cancer in the population.

SOURCE:  The Lancet, online October 22, 2010.

RELATED STORIES:
There’s an App for Colon Cancer   Less Invasive CT-Scan Based Colorectal Cancer Screening Method Shows Good Accuracy   Study Sets Treatment Standard for Elderly with Colon Cancer   Fat Intake and Colorectal Cancer   Curry compound may prevent colon cancer   Western and Japanese diets up colon cancer risk   Can a Cholesterol Drug Prevent Colon Cancer?   Bowel cancer: 8 years of colonoscopy screening in Germany—a success story   Genetic ID of Marker in Lymph Nodes May be Linked to Colorectal Cancer Recurrence Risk   Some Early Stage Colon Cancer Patients Should Not Receive Chemotherapy   Colorectal cancer risk appears unaffected by coffee   Tips to Lower Risk of Colorectal Cancer; New Combined Colonoscopy Procedure Avoids Major Surgery   New report says racial gap growing in colorectal cancer   Magnesium may curb colon cancer risk in women   Age differences seen in rectal cancer treatment   Colonoscopy Prevents Deaths From Colon Cancer   Morbidly obese patients face high risk for complications after colectomy   Doctors fail to recommend colon cancer tests for low-income patients   Colorectal Cancer More Common Among Diabetics   City of Hope researchers to present rectal cancer, palliative care, benchmarking studies at ASCO   Biomarker Predicts Disease Recurrence in Colorectal Cancer   Study reveals differences in cancer stage presentation between rural and urban patients

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]